TELIF - Telescope Innovations Corp.
| Previous Close | 0.1153 |
| Open | 0.1153 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.1153 - 0.1153 |
| 52 Week Range | 0.1100 - 0.2769 |
| Volume | |
| Avg. Volume | 782 |
| Market Cap | 6.188M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 0.82 |
| EPS (TTM) | 0.1400 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NewsfileTelescope Reports First Profitable Quarter: Fiscal Quarter 2, 2023
Vancouver, British Columbia--(Newsfile Corp. - April 25, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the second fiscal quarter ended February 28, 2023. Just over one year after securing facilities, assembling a team, and outfitting a research laboratory, the Company posted its third consecutive quarter of
NewsfileTelescope Reports First Fiscal Quarter 2023 Results
Vancouver, British Columbia--(Newsfile Corp. - February 8, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the first fiscal quarter ended November 30, 2022. The Company also announces its participation in investor events and technical conferences."We are pleased to report our second consecutive quarter of rev
NewsfileTelescope Presents 2022 Fiscal Year Highlights and Investor Update
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, provides a financial and corporate update.KEY HIGHLIGHTSTelescope generated revenues of CAD $595,398 in its first full fiscal year of operation ending August 31, 2022 A new Master Services Agreement with Aqualung Carbon Capture Four
NewsfileINVITATION: Winter Investor Series at the Vancouver Club: January 10th, 2023
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2023) - Investor.Events would like to invite the Investment Community to its Winter Investor Series being held at the Vancouver Club in Vancouver, British Columbia on Tuesday January 10th, 2023! Individual Investors, Institutional Investors, Advisors, and Analysts are invited to register to attend the event.Registration Link: https://www.eventbrite.ca/e/investor-series-at-the-vancouver-club-tickets-443443560627Banner for Investor Series'
NewsfileTelescope Announces Closing of $1.46 Million Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce that it has closed a non-brokered private placement (the "Offering").Upon closing of the Offering, the Company issued a total of 4,879,499 units ("Units") at a price of $0.30 per Unit for aggregate gross proce
NewsfileTelescope Announces Engagement with Natural Resources Canada to Develop Lithium Refinement Technology
Vancouver, British Columbia--(Newsfile Corp. - October 24, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces that it has been contracted by Natural Resources Canada ("NRCan") to help develop a critical lithium refinement technology. Over 16 months, Telescope will collaborate with NRCan to build an autonomous, self-driving experime
NewsfileSecond Nobel Prize Won by Telescope Innovations Advisor
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced chemical technologies, announced today that K. Barry Sharpless, a member of Telescope's Scientific Advisory Board, and W.M. Keck Professor of Chemistry at Scripps Research, was awarded the 2022 Nobel Prize in Chemistry. Prof. Sharpless shares the award with Carolyn Bertozzi of Stanford and Morten Meldal of the Uni
NewsfileTelescope Welcomes Dr. Jeffrey Sherman as Chief Operating Officer
Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce that Dr. Jeffrey Sherman has accepted the position of Chief Operating Officer of the Company. Jeff brings over thirty years of experience in the scientific instrument industry. He has worked with emerging tech
NewsfileTelescope Upgrades US Listing to OTCQB
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - Telescope Innovations Corp. ("Telescope" or the "Company") (CSE: TELI), a chemical technology company, is pleased to report that Telescope's U.S. ticker symbol "TELIF" has been upgraded to trade on the OTCQB market effective September 1, 2022. It is anticipated that Telescope's upgraded listing to the OTCQB will provide greater liquidity and a more seamless trading experience for our U.S. shareholders. With enhanced reporting re
NewsfileTelescope Completes Feasibility Research Project Funded by Pfizer
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Telescope Innovations Corp. (CSE: TELI) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces that it has completed a four-month feasibility project funded by Pfizer to explore the acceleration of pharmaceutical process development through the use of automation. To successfully complete this project, Telescope created a proof-of-co
NewsfileTelescope Inks Research Agreement with Standard Lithium
Vancouver, British Columbia--(Newsfile Corp. - July 13, 2022) - Telescope Innovations Corp. (CSE: TELI) ("Telescope" or the "Company"), a chemical technology company, announces that it has signed a Master Service Agreement ("MSA") with Standard Lithium Ltd. ("SLI"). For the first project under this MSA, Telescope will receive funding for one year to evaluate the utilization and sequestration of CO2 within the lithium brine extraction and reinjection processes developed by SLI. This project bolst
NewsfileTelescope Launches First Automation Product
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2022) - Telescope Innovations Corp. (CSE: TELI) ("Telescope" or the "Company"), a chemical technology company, announces the creation of "Telescope Automation", a division of the Company that develops automated systems to accelerate chemical and biopharmaceutical research and development. Telescope Automation is pleased to launch its first product, the Direct Inject Liquid Chromatography ("DILC") platform, an innovative instrument for real-